ProfileGDS4132 / 227843_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 25% 21% 29% 34% 31% 22% 24% 22% 29% 33% 31% 25% 26% 28% 38% 37% 28% 25% 29% 30% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10159.704925
GSM201543Muscle PCOS pioglitazone 12140.463921
GSM201544Muscle PCOS pioglitazone 16174.647629
GSM201545Muscle PCOS pioglitazone 20192.541934
GSM201829Muscle PCOS pioglitazone 23180.903531
GSM201830Muscle PCOS pioglitazon 25151.974322
GSM201831Muscle PCOS pioglitazone 27153.465124
GSM201832Muscle PCOS pioglitazone 3152.303322
GSM201833Muscle PCOS pioglitazone 4167.505329
GSM201834Muscle PCOS pioglitazone 8179.580733
GSM201835Muscle PCOS after pioglitazone 10262.061331
GSM201836Muscle PCOS after pioglitazone 12249.100525
GSM201837Muscle PCOS after pioglitazone 16250.438326
GSM201838Muscle PCOS after pioglitazone 20260.2828
GSM201839Muscle PCOS after pioglitazone 23291.572138
GSM201840Muscle PCOS after pioglitazone 25290.740737
GSM201841Muscle PCOS after pioglitazone 27255.043428
GSM201842Muscle PCOS after pioglitazone 3244.776625
GSM201843Muscle PCOS after pioglitazone 4268.671429
GSM201844Muscle PCOS after pioglitazone 8269.170230